Abstract: The present disclosure provides orally deliverable pharmaceutical compositions comprising DGLA and to methods of using same to treat a variety of conditions and disorders.

Abstract: Aspects of the disclosure provide techniques that enable a communication server hosting a virtual communication session to receive theme parameters from a remote server to control the look and feel of the virtual communication session. In one example, a method includes sending a plurality of video feeds for display at a plurality of graphical user interfaces (GUIs) of client devices coupled to a communication session. The communication session enables communication among a plurality of users of the client devices. The method also includes receiving a set of parameters of a theme to modify one or more visual properties of the GUIs. The method also includes sending the set of parameters to the client devices connected to the communication session to modify visual properties of the GUIs displaying the plurality of video feeds at the plurality of client devices based on the parameters of the theme.

Abstract: Systems and methods provide for detection and controlled interaction with one or more objects. The system can include an imaging subsystem (20), a tool subsystem (26) containing one or more tools, a stage subsystem (16) and a control system (40). The control system (40) can integrate controls for each of the other subsystems, which controls can be implement desired functions over a variety of process parameters to perform the controlled interaction.

Abstract: The methods disclosed herein include recording at near-vertical first and second measurement positions respective first and second interferograms of the photomask surface and defining a difference map as the difference between the first and second interferograms. Respective first and second normal forces on the photomask are also measured at the first and second measurement positions. The change in the normal force is used define a scaling factor, which is applied to the difference map to define a scaled difference map. A compensated flatness measurement with a reduced shape contribution due to gravity is obtained by subtracting the scaled difference map from the first interferogram. An interferometer-based flatness measurement system is also disclosed.

Abstract: The present disclosure provides orally deliverable pharmaceutical compositions comprising DGLA and to methods of using same to treat a variety of conditions and disorders.

Abstract: A metrology apparatus has an illumination source that directs collimated light to a reference surface and to an optical component having a test surface that is in parallel with the reference surface. A first imaging lens defines a Fourier transform plane for light reflected from the reference surface and the test surface. A spatial filtering element is actuable to a blocking position that blocks specular light at the transform plane. A second imaging lens forms, at an image plane, an image of the test surface. A sensor array generates image data from received light at the image plane.

Abstract: A chemical impairment detection system adaptable for use in a vehicle. The impairment detection system includes an intake adapted to receive an air sample from a source and an alcohol sensor for detecting an alcohol level in the air sample. An integrated breath chamber channels the air sample from the intake to the alcohol sensor. Source evaluator means in the breath chamber measure one or more characteristics of the received air sample for validating the sample. The source evaluator means measures the air sample characteristics as the air sample flows through the breath chamber.

Abstract: The present disclosure provides orally deliverable pharmaceutical compositions comprising DGLA and to methods of using same to treat a variety of conditions and disorders.

Abstract: The present disclosure provides orally deliverable pharmaceutical compositions comprising DGLA and to methods of using same to treat a variety of conditions and disorders.

Abstract: The present disclosure provides orally deliverable pharmaceutical compositions comprising DGLA and methods of using same to treat a variety of conditions and disorders.

Abstract: A camera system is configured to capture video content with 360 degree views of an environment. The camera array comprises a housing including a first quadrant, a second quadrant, a third quadrant, and a fourth quadrant, wherein each of the first quadrant, the second quadrant, the third quadrant, and the fourth quadrant form a plurality of apertures, a chassis bottom that is removably coupled to the housing, and a plurality of camera modules, each camera module comprising a processor, a memory, a sensor, and a lens, wherein each of the camera modules is removably coupled to one of the plurality of apertures in the housing, wherein the first quadrant, the second quadrant, the third quadrant, and the fourth quadrant each include a subset of the plurality of camera modules. Each of the plurality of camera modules includes a heat sink.

Abstract: A camera system is configured to capture video content with 360 degree views of an environment. The camera array comprises a housing including a first quadrant, a second quadrant, a third quadrant, and a fourth quadrant, wherein each of the first quadrant, the second quadrant, the third quadrant, and the fourth quadrant form a plurality of apertures, a chassis bottom that is removably coupled to the housing, and a plurality of camera modules, each camera module comprising a processor, a memory, a sensor, and a lens, wherein each of the camera modules is removably coupled to one of the plurality of apertures in the housing, wherein the first quadrant, the second quadrant, the third quadrant, and the fourth quadrant each include a subset of the plurality of camera modules. Each of the plurality of camera modules includes a heat sink.

Abstract: An organ lengthening device comprising a spring-like structure, wherein the surface of the device is covered with micron-size anchors such as hooks, studs or wires made from a biodegradable polymer. The anchors are configured to engage the surface of the organ so that the device will be anchored to the organ. The device, which is inserted into the organ in a compressed position, gradually lengthens over time, thereby lengthening the organ, wherein the anchors are configured to degrade away and eventually allow the device to become disengaged from the organ.

Abstract: The present disclosure provides orally deliverable pharmaceutical compositions comprising DGLA and to methods of using same to treat a variety of conditions and disorders.

Abstract: The present disclosure provides orally deliverable pharmaceutical compositions comprising DGLA and to methods of using same to treat a variety of conditions and disorders.

Abstract: The present disclosure provides orally deliverable pharmaceutical compositions comprising DGLA and to methods of using same to treat a variety of conditions and disorders.